Current Affairs - Science
Why should I study the current affairs questions and answers section on "Science" daily?
Read the daily current affairs questions and answers section on "Science" to enhance your general knowledge for clearing competitive examinations and placement interviews.
Where can I get the current affairs questions and answers section on "Science"?
IndiaBIX provides you with daily current affairs questions and answers with explanations.
Where can I get the current affairs MCQ questions and answers section on "Science" (objective type, multiple choice)?
Here you can find multiple-choice-type current affairs questions and answers on "Science" for your interviews and competitive examinations. All the CA questions are arranged in different categories, including date-wise.
How do I download the current affairs questions section on "Science" in PDF format?
You can download the current affairs quiz questions and answers section on "Science" as PDF files or eBooks.
How do I answer the current affairs quiz section on "Science"?
You can answer any current affairs quiz question on "Science" by reading this current affairs section daily.
Exercise : Science - Latest Current Affairs
- Science - Latest Current Affairs
1.
What percentage of all diseases in India is accounted for by cardiovascular diseases according to the NSO Survey 2025?
Answer: Option
Explanation:
Cardiovascular diseases have emerged as a major health concern in India, showing a significant increase over recent years. According to the NSO Survey 2025, these diseases now account for 25.6% of all reported illnesses, making them the leading category among various health conditions. This rise reflects changing lifestyles, increased stress levels, and other risk factors such as poor diet and lack of physical activity. Notably, the impact is not limited to older populations, as younger age groups are also increasingly affected. The data highlights the urgent need for improved public health strategies, awareness campaigns, and preventive healthcare measures to address this growing burden.
Date : 2026-05-04
2.
Which disease is Coartem Baby specifically developed to treat in newborns and infants?
Answer: Option
Explanation:
Malaria is the disease targeted by Coartem Baby, the first WHO-prequalified drug specifically designed for newborns and infants. Developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), this medication addresses a critical gap in pediatric treatment. It uses an artemether-lumefantrine combination and is suitable for infants weighing between 2 to 5 kilograms. The disease remains a major global health concern, causing millions of cases and deaths annually, especially among children under five in Africa, making this innovation a significant breakthrough.
Date : 2026-04-27
3.
Into how many regional languages will Ayurveda research materials be translated under the CCRAS and Anuvadini AI partnership?
Answer: Option
Explanation:
The collaboration between the Central Council for Research in Ayurvedic Sciences (CCRAS) and Anuvadini AI focuses on making Ayurveda research widely accessible by translating it into multiple regional languages. The initiative specifically targets 13 languages, including Hindi, to ensure that valuable scientific and educational content reaches a broader audience across India. This effort helps bridge linguistic barriers, making traditional medical knowledge more inclusive and understandable. By leveraging artificial intelligence, the program enhances the dissemination of authentic information, supports regional outreach, and reduces misinformation, especially in rural and linguistically diverse populations.
Date : 2026-03-31
4.
Which disease is the focus of the collaborative clinical study announced by the Ministry of Ayush and DBT using Ayurveda as an adjunct therapy?
Answer: Option
Explanation:
The collaborative clinical study launched by the Ministry of Ayush and the Department of Biotechnology focuses on Tuberculosis, aiming to integrate Ayurveda with standard Anti-Tuberculosis Treatment. This approach seeks to enhance recovery outcomes, improve nutrition, and elevate the quality of life for patients. A major focus is on managing TB-related cachexia, a condition involving severe weight and muscle loss. Conducted over a 24-month period across leading medical institutions such as AIIMS and JIPMER, the study reflects a scientific effort to validate traditional medicine through evidence-based research and promote holistic healthcare solutions.
Date : 2026-03-25
5.
Which company has launched an affordable Semaglutide injection in India using an innovative multi-dose pen?
Answer: Option
Explanation:
Zydus has introduced an affordable Semaglutide injection in India, targeting the treatment of Type 2 Diabetes Mellitus and obesity. The innovation includes a reusable multi-dose pen, allowing patients to adjust dosages conveniently from a single device, unlike traditional single-use pens. This significantly improves ease of use and reduces treatment costs, with an average monthly expense of around ₹2,200. Manufactured at the Zydus Biotech Park in Ahmedabad, the product aims to make GLP-1 therapies more accessible, especially in a country facing a growing burden of diabetes and rising obesity rates.
Date : 2026-03-23
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers